Gene · 55509
Papers1,335
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,335
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Real-world insights into genomic reprogramming during CAR-T cell manufacturing in India. | Front Immunol | 2026 | 42756106 | PubTator, text mining | PubMed |
| Dendritic cell centric nanoengineering couples antigen acquisition and STING activation for cancer immunotherapy. | Cell Rep Med | 2026 | 42705236 | PubTator, text mining | PubMed |
| CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity. | Cell Rep Med | 2026 | 42679804 | PubTator, text mining | PubMed |
| Clinical translation of epigenome editing technologies. | Curr Opin Biomed Eng | 2026 | 42582990 | PubTator, text mining | PubMed |
| Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression. | Leukemia | 2026 | 42533032 | PubTator, text mining | PubMed |
| The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity. | Science | 2026 | 42424445 | PubTator, text mining | PubMed |
| Temporal changes in gene regulation during human tissue repair. | Sci Rep | 2026 | 42259926 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals a persistent interferon signature in immune cells from systemic lupus erythematosus patients with high versus low polygenic risk scores despite antimalarial treatment. | J Autoimmun | 2026 | 42119160 | PubTator, text mining | PubMed |
| What Is-and What Is Not-Immunogenic Cell Death? Functional Definitions, Experimental Standards, and Common Pitfalls. | Int J Mol Sci | 2026 | 41977247 | PubTator, text mining | PubMed |
| BATF3 regulates differentiation of CD8+ T lymphocytes and memory differentiation program. | Life Sci Alliance | 2026 | 41974573 | PubTator, text mining | PubMed |
| From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma. | J Pers Med | 2026 | 41893014 | PubTator, text mining | PubMed |
| c-MYC enhances transcription of the type 1 diabetes mellitus associated gene BATF3 via promoter binding. | Sci Rep | 2026 | 41882260 | PubTator, text mining | PubMed |
| Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation. | Immune Netw | 2026 | 41800027 | PubTator, text mining | PubMed |
| Targeting cellular source-specific CXCL9 signaling for immunotherapy in oral squamous cell carcinoma. | Front Immunol | 2026 | 41766875 | PubTator, text mining | PubMed |
| Transforming Gastric Biopsy Diagnostics: Integrating Omics Technologies and Artificial Intelligence. | Biomedicines | 2026 | 41751306 | PubTator, text mining | PubMed |
| Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. | Blood Cancer J | 2026 | 41741411 | PubTator, text mining | PubMed |
| Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy. | Innovation (Camb) | 2026 | 41737316 | PubTator, text mining | PubMed |
| Glycolysis in the tumor microenvironment shapes dendritic cell function and antitumor immunity. | Front Immunol | 2026 | 41737218 | PubTator, text mining | PubMed |
| OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives. | Front Immunol | 2026 | 41737211 | PubTator, text mining | PubMed |
| Pan-cancer analysis of ALK mutation and its association with tumor immunogenicity and the efficacy of immune checkpoint blockade. | Genes Dis | 2026 | 41716637 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55509/papers